Location History:
- Seoul, KR (2010 - 2015)
- Daejeon, KR (2015)
Company Filing History:
7 out of 321 
1 out of 19 
Years Active: 2010-2015
Title: Eun Young Song: Innovator in Cancer Treatment
Introduction
Eun Young Song is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and development. With a total of 7 patents, his work focuses on pharmaceutical compositions and diagnostic markers for cancer.
Latest Patents
One of his latest patents involves a pharmaceutical composition for treating cancer. This invention comprises deoxyribonucleic acids (DNA) that encode small interfering RNA (siRNA) which complementarily binds to the base sequence of the transcript of the FLJ25416 gene. This composition aims to inhibit the intracellular expression of the FLJ25416 gene, which is known to be expressed in cancer cells, thereby providing a novel anti-cancer agent. Another significant patent relates to biomarkers for gastric cancer, specifically CST1, DCC1, IFITM1, and MELK. This invention includes a diagnostic composition for gastric cancer that measures the expression levels of these markers, along with methods for detecting them and screening therapeutic agents.
Career Highlights
Eun Young Song has worked with notable organizations such as the Korea Research Institute of Bioscience and Biotechnology and St Pharm Co., Ltd. His experience in these institutions has allowed him to advance his research and contribute to the development of effective cancer treatments.
Collaborations
Throughout his career, Eun Young Song has collaborated with esteemed colleagues, including Young Il Yeom and Hee Gu Lee. These partnerships have fostered a collaborative environment that enhances innovation and research in cancer treatment.
Conclusion
Eun Young Song's contributions to cancer research and treatment exemplify the impact of innovation in the medical field. His patents and collaborations highlight the importance of continued research in developing effective therapies for cancer patients.